H.C. Wainwright cuts Aardvark Therapeutics target price to $4 from $6
AARD•H.C. Wainwright cut its target price for Aardvark Therapeutics to $4 from $6.
Related News
The GEO Group completes redemption of all senior secured notes due 2029
GEO•
MGM Resorts International: Morgan Stanley cuts target price to $29 from $43
MGM•
Boyd Gaming raised to overweight by Morgan Stanley; target price cut to $83 from $89
BYD•
Curaleaf Holdings challenges Aurora's unilateral rejection of its enhanced proposal
ACB•
Advantage Solutions tightens bylaw requirements for stockholder director nominations
ADV•